Edaravone CAS 89-25-8; 1-Pheny-3-Methyl-5-Pyrazolone (PMP) High Purity
Supply with High Purity and Stable Quality
Name: Edaravone
CAS: 89-25-8
| Name | Edaravone |
| Synonyms | 1-Pheny-3-Methyl-5-Pyrazolone (PMP); MCI-186 |
| CAS Number | 89-25-8 |
| CAT Number | RF-PI237 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C10H10N2O |
| Molecular Weight | 174.2 |
| Density | 1.12 g/cm3 |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Appearance | Light Yellow Crystal or Powder |
| Purity | ≥99.0% |
| Melting Point | 127.0~130.0℃ |
| Loss on Drying | ≤0.50% |
| Residue on Ignition | ≤0.30% |
| Single Impurity | ≤0.50% |
| Total Impurities | ≤1.0% |
| Heavy Metals | ≤20ppm |
| Solubility | Soluble in 5% Hydrochloric Acid |
| Test Standard | Enterprise Standard |
| Usage | API; Pharmaceutical Intermediates |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Edaravone (CAS 89-25-8) is a potent new free radical scavenger used for the therapy of patients with acute brain infarction. Edaravone is a radical scavenger and antioxidant which is able to protect against the effects of ischemia, probably by inhibiting the lipoxygenase system. Protects against MPTP-induced neurotoxicity. Inhibits autophagy. Edaravone was marketed in Japan for improving neurologic recovery following acute brain infarction. Currently, several agents classified as neuroprotectants and acting by diverse mechanisms (inhibition of glutamate release, blockade of calcium channels, lazaroids) have been marketed for treating the outcomes of brain damage due to trauma, ischemia or cardiac arrest. Edavarone is the first antioxidant with free radical scavenging activity to be introduced for this pathology.
